Volume 47, Number 11, 1948-1952, DOI: 10.1007/s00125-004-1553-x

Published in partnership with the

Logo

European Association for the Study of Diabetes

Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance

L. Fogelstrand, J. Hulthe, L. M. Hultén, O. Wiklund and B. Fagerberg

View Related Documents

Abstract

Aims/hypothesis  

Type 2 diabetes is a major risk factor for cardiovascular disease. Monocyte recruitment and inflammatory activation are crucial steps in the development of atherosclerosis and several receptors are involved in these processes. The aim of this study was to investigate levels of CD14 and the beta2-integrin subunits CD11b and CD18 on monocytes from women with diabetes or impaired glucose tolerance.

Methods  

A population-based sample of 112 Swedish women, who were aged 64 years and had diabetes mellitus or impaired or normal glucose tolerance, was investigated. Cell surface receptors were analysed with flow cytometry and serum inflammation markers and soluble adhesion molecules with enzyme-linked methods.

Results  

The monocytic CD14 expression and serum levels of C-reactive protein, IL-6 and soluble adhesion molecules were higher in the diabetes group than in the group with normal glucose tolerance. Monocytic CD18 was elevated both in the diabetes and in the impaired glucose tolerance groups. The levels of monocytic surface markers correlated with BMI and to a lesser extent with glycaemic control.

Conclusions/interpretation  

The increased monocytic expression of important surface receptors together with elevated serum inflammation markers supports the concept of increased inflammation in type 2 diabetes and may be an important factor for the risk of atherosclerosis.

Keywords  Adhesion molecule - Atherosclerosis - CD14 - CD18 - Diabetes - Integrin - Monocyte

The authors state that no conflicts of interest exist.

Fulltext Preview

Image of the first page of the fulltext document